Description: Equity-Based Insurance Guarantee Webcast Series

Description: "New regulatory requirements demonstrate an increased focus on understanding the liquidity and behavioral risks of structured assets and the close association and interaction with liability lapse risk. In the US, Actuarial Guideline LIII (“AG53”) requires additional analysis & disclosure around the risks of structured, less liquid assets used to back insurance liabilities. In Bermuda, the implementation of Consultation Paper #2 includes several targeted requirements to capture lapse risk, asset behavioral risk, and liquidity risk in a more robust and dynamic way. These emerging requirements necessitate enhanced ALM modeling capabilities and a more holistic view of liquidity risk that incorporates both sides of the balance sheet. In this session, we will discuss these requirements, what companies are doing to fulfill them, and how their efforts feed into a broader improvement of the ALM function."

Description: Gather with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, pension, investment, product strategy, and more.

Description: This session will address the risk management, reserving and capital issues associated with index-linked annuities including financial reporting considerations for FIAs and RILAs, benefits of combining VA and RILA hedging and reserving under VM-21, current and future challenges with FIA reserving under VM-22, potential capital redundancy for FIAs, RILA interim values under AG 54, NAIC economic scenario reform, asset modeling, fund mapping and more!

Description: June 2024, AG54 will begin for new RILA sales. This guidance requires companies to determine an interim value that is more aligned with the market value of the position on a daily basis. This discussion will talk through companies adoption of AG54, lessons learned, approaches and integration with the administration system. Additionally this session will discuss how AG54 impacts new product design, reserving and capital implications.